LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Papaya Leaf Extract Slows Growth of Cancer Cell Cultures

By LabMedica International staff writers
Posted on 23 Mar 2010
Cancer researchers have found that a water extract prepared from dried papaya leaves has potent anticancer properties when tested on cultures of cells taken from more than 10 different types of tumors.

Investigators at the University of Florida (Gainesville, FL, USA) and the University of Tokyo (Japan) sought to bring scientific order to folk anecdotes on the anticancer properties of papayas. Their plan was to examine the effect of an aqueous-extracted papaya leaf fraction on the growth of various tumor cell lines and on the antitumor effect of human lymphocytes. In addition, they attempted to identify the functional molecular weight fraction in the papaya leaf extract. In this study the effect of papaya leaf extract on the proliferative responses of tumor cell lines and human peripheral blood mononuclear cells (PBMC), and cytotoxic activities of PBMC were assessed by the incorporation of radioactive thymidine. Flow cytometric analysis and measurement of caspase-3/7 activities were performed to confirm the induction of apoptosis on tumor cells. Cytokine productions by PBMC were measured by ELISA. Gene profiling of the effect of leaf extract treatment was performed by microarray analysis and real-time RT-PCR.

Results published in the February 17, 2010, issue of the Journal of Ethnopharmacology revealed that papaya leaf extract showed significant growth inhibitory activity on cervix, breast, liver, lung, and pancreas tumor-cell lines. In PBMCs, the production of interleukin-2 (IL-2) and IL-4 was reduced following the addition of leaf extract, whereas that of IL-12p40, IL-12p70, IFN-gamma (interferon-gamma) and TNF-alpha (tumor necrotic factor-alpha) was enhanced without growth inhibition. In addition, cytotoxicity of activated PBMCs was enhanced by the addition of the extract. Moreover, microarray analyses showed that the expression of 23 immunomodulatory genes, classified by gene ontology analysis, was enhanced by the addition of papaya leaf extract.

The investigators identified the active component of the papaya leaf extract, which inhibited tumor cell growth and stimulated anti-tumor effects, to be a fraction with molecular weight less than 1,000. Importantly, the papaya extract did not have any toxic effects on normal cells.

"Based on what I have seen and heard in a clinical setting, nobody who takes this extract experiences demonstrable toxicity; it seems like you could take it for a long time — as long as it is effective,” said contributing author Dr. Nam Dang, professor of hematology and oncology at the University of Florida.

Related Links:
University of Florida
University of Tokyo


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Rapid Molecular Testing Device
FlashDetect Flash10

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more